Detailed description of all materials and methods used are provided in the online-only Data Supplement.
I mprovement of medical treatment algorithms and technologies resulted in increased survival of myocardial infarction throughout the past years. 1 Concomitantly, cardiovascular morbidity attributable to heart failure and its underlying myocardial remodeling processes is spreading in industrialized countries. Signifi cant improvement in treatment strategies for these patients is required to close the gap of these unmet needs.
The Wnt signaling pathway is evolutionarily conserved throughout the metazoa and controls various developmental processes, including early cardiogenesis. 2 -5 The Wnt cascade is inactive in adult hearts; however, recent studies indicate that this pathway is involved in myocardial remodeling after pathological injury. This is supported by our recent study in which cardiac-specifi c overexpression of dishevelled (Dvl)1 in mice activates the Wnt pathway and induces severe cardiac remodeling. 6 Dvl proteins are fundamental molecules to regulate Wnt activity. They exist in 3 isoforms (Dvl1 -Dvl3) with partly redundant functions. 7 In canonical Wnt signaling, Wnt ligands bind to frizzled receptors and recruit Dvl to the plasma membrane. In turn, Dvl mediates the stabilization and accumulation of β -catenin in the cytoplasm and its translocation into the nucleus, where it interacts with transcription factors of the T-cell factor/lymphoid enhancer factor (TCF/LEF) family to induce the expression of specifi c targets, including c-myc, cyclin D1, and peroxisome proliferator-activated receptor-δ . 8 Among other members of the Wnt pathway, Dapper-1 (Dpr1, also called Dact1 or Frodo) interacts with Dvl proteins in a tissue-and context-dependent manner. Although, so far in general, Dpr1 is considered as a negative Wnt regulator, its substantial contribution to Wnt signaling is not unambiguous.
To date, the role of Dpr1 in cardiac tissue and isolated cardiomyocytes remains unexplored. We observed strong upregulation of Dpr1 in the remote area 1 week after myocardial infarction and in isolated cardiomyocytes cultured in hypoxia conditions, leading us to further examine the role of Dpr1 for myocardial function and in Wnt signal transduction. We present evidence that Dpr1 is a positive regulator of canonical Wnt signaling in myocardial tissue and in cultured cardiomyocytes, and show furthermore that Dpr1-mediated activation of the canonical Wnt pathway induces cardiac remodeling and impairs left ventricular (LV) function. mprovement of medical treatment algorithms and technologies resulted in increased survival of myocardial infarction throughout the past years. 1 Concomitantly, cardiovascular morbidity attributable to heart failure and its underlying myocardial remodeling processes is spreading in industrialized countries. Signifi cant improvement in treatment strategies for these patients is required to close the gap of these The Wnt signaling pathway is evolutionarily conserved throughout the metazoa and controls various developmental processes, including early cardiogenesis. 2 -5 The Wnt cascade transcription factors of the T-cell factor/lymphoid enhancer factor (TCF/LEF) family to induce the expression of specifi c targets, including c-myc, cyclin D1, and peroxisome proliferator-activated receptor-δ . 8 Among other members of the Wnt pathway, Dapper-1 (Dpr1, also called Dact1 or Frodo) interacts with Dvl proteins in a tissue-and context-dependent manner. Although, so far in general, Dpr1 is considered as a negative Wnt regulator, its substantial contribution to Wnt signaling is not unambiguous.
To date, the role of Dpr1 in cardiac tissue and isolated cardiomyocytes remains unexplored. We observed strong
Results

Robust Overexpression of Dpr1 in a Rat Myocardial Infarction Model
We observed robust overexpression of Dpr1 protein and mRNA in the remote area of rat myocardial infarction tissue and in isolated cardiomyocytes, cultured under hypoxia conditions ( Figure 1A and 1B , Figure S1A -S1D in the online-only Data Supplement), suggesting involvement of Dpr1 in early cardiac remodeling. In addition, Dpr1 accumulation in the cytoplasm and increased nuclear localization in hypoxia cells were determined ( Figure 1C ). This prompted us to elucidate the function of Dpr1 in the heart. Therefore, we genetically engineered transgenic mice (Dpr1-tg) with cardiac-specifi c overexpression of Dpr1 under the control of an α -myosin heavy chain promotor. Upregulation of Dpr1 in cardiac tissue was confi rmed by immunoblotting ( Figure S1E ). Animals were characterized at 3 months of age.
Dpr1 Induces Cardiac Hypertrophy and Impairs LV Function
Dpr1-tg mice exhibited a higher heart weight/tibia length ratio and increased left and right ventricular weight/tibia length ratio than wild-type (WT) animals (7.6 ± 0.2 mg/mm versus 7.0 ± 0.2 mg/mm, 5.6 ± 0.1 mg/mm versus 5.2 ± 0,1 mg/mm, 1.3 ± 0.09 mg/mm versus 1.1 ± 0.05 mg/mm, respectively; P < 0.05; Figure  2A -2C ). Cardiomyocyte cross-sectional area was increased in mice overexpressing Dpr1 (+21 ± 2% versus WT animals; P < 0.05; Figure 2D and 2E). In line with these fi ndings, upregulation of prominent hypertrophy marker genes atrial natriuretic factor, brain natriuretic peptide, and β -myosin heavy chain was observed ( Figure 2F ). Baseline echocardiography revealed no signifi cant difference between Dpr1-tg mice and WT animals in ejection fraction ( Figure 2G ), end-systolic, and end-diastolic diameter (data not shown). However, cardiac hypertrophy was associated with impairment of LV function. Pressure -volume loop analysis revealed a decrease in the maximal rise of LV pressure (dp/dt max; 10 878 ± 2669 mm Hg/s in WT versus 8498 ± 2044 mm Hg/s in Dpr1-tg mice; P < 0.005; Figure 2H ), indicating impaired contractility in Dpr1-tg mice. The reduction in dp/dt min levels ( − 8920 ± 435 mm Hg/s in WT versus − 7529 ± 451 mm Hg/s in Dpr1-tg mice; P < 0.01; Figure 2I ) and the simultaneous increase in the time constant of isovolumic relaxation (10.24 ± 0.6 m/s in WT mice versus 12.2 ± 0.3 m/s in Dpr1-tg mice; P < 0.01; Figure 2J ) demonstrate signs of diastolic dysfunction compatible with the myocardial hypertrophy observed.
Dpr1 Activates Canonical Wnt Signaling Pathway in the Murine Heart
Dpr1-tg mice had increased Dvl2 protein levels and mRNA transcripts, whereas expression of Dvl1 and Dvl3 isoforms remained unaltered ( Figure 3A , Figure S2A and S2B). In addition, we observed enhanced Dvl2 phosphorylation ( Figure 3A ), indicating higher Dvl2 activity. Given the redundancy of Dvl proteins, we asked whether this was suffi cient to activate canonical Wnt signaling and found increased total-and activated β -catenin amounts, but reduction of β -catenin (pS33/37, pT41; Figure 3B and Figure  S2C ). Phosphorylation of β -catenin primes this protein for degradation. Immunostaining of LV tissue slides revealed β -catenin accumulation in the cytoplasm and its translocation into the nucleus ( Figure 3C ). Steady-state levels of β -catenin mRNA transcripts suggest post-translational stabilization ( Figure S2D ). Stabilized β -catenin was accompanied by transcription of Wnt/ β -catenin targets c-myc, cyclin D1, peroxisome proliferator-activated receptor-δ , and myoD, all indicating activation of canonical Wnt signaling ( Figure 3D ).
Dpr1 Is Both Necessary and Suffi cient to Activate Canonical Wnt Signaling in Cardiomyocytes
We further mapped the molecular mechanism by which Dpr1 impacts canonical Wnt signaling in cultured cardiomyocytes by siRNA-mediated Dpr1 depletion. Consistent with our observations in Dpr1-tg mice, we detected decreased Dvl2 protein abundance but unaltered expression of Dvl1 and Coomassie staining was used as loading control. C , Fluorescence image of cardiomyocytes exposed to hypoxia for 24 hours. Dpr1 (red) accumulates in the cytoplasm and translocates into the nucleus (blue). than wild-type (WT) animals (7.6 ± 0.2 mg/mm versus 7.0 ± 0.2 mg/mm, 5.6 ± 0.1 mg/mm versus 5.2 ± 0,1 mg/mm, 1.3 ± 0.09 mg/mm versus 1.1 ± 0.05 mg/mm, respectively; P < 0.05; Figure  2A -2C ). Cardiomyocyte cross-sectional area was increased in mice overexpressing Dpr1 (+21 ± 2% versus WT animals; < 0.05; Figure 2D and 2E). In line with these fi ndings, upregulation of prominent hypertrophy marker genes atrial natriuretic factor, brain natriuretic peptide, and β -myosin heavy chain was observed ( Figure 2F ). Baseline echocardiography revealed no signifi cant difference between Dpr1-tg mice and WT animals in ejection fraction ( Figure 2G ), end-systolic, and end-diastolic diameter (data not shown). However, cardiac hypertrophy was associated with impairment of LV func-β -catenin accumulation in the cytoplasm and its translocation into the nucleus ( Figure 3C ). Steady-state levels of mRNA transcripts suggest post-translational stabilization ( Figure S2D ). Stabilized β -catenin was accompanied by transcription of Wnt/ β -catenin targets c-myc, cyclin D1, peroxisome proliferator-activated receptor-δ indicating activation of canonical Wnt signaling ( Figure 3D ). Dvl3 ( Figure 4A and Figure S3A ). Numbers of Dvl2 mRNA copies were not reduced, suggesting a mechanism on levels after transcription ( Figure S3B ). Inhibition of lysosome acidifi cation with NH 4 Cl stabilized Dvl2 proteins in Dpr1depleted cells, indicating that downregulation of Dvl2 is a result of lysosomal degradation ( Figure 4B and Figure S3C ). Downstream of Dvl2, these cells displayed reduced totaland active β -catenin protein amounts, as well as inhibition of c-myc protein expression ( Figure 4A and Figure S3B ). Copy number of β -catenin mRNA was stable, suggesting that decreased protein content is a result of post-translational reduction ( Figure S3E ).
Wnt3a-conditioned medium specifi cally activates β -catenin -dependent Wnt signaling. Cellular distribution of Dpr1 on Wnt3a stimulation changed from the cytoplasm to the nucleus and underlines its role in canonical Wnt signaling ( Figure S3F ). To determine whether Dpr1 depletion was suffi cient to inhibit transmission of canonical Wnt signals, we fi rst assayed β -catenin activation after Wnt3a treatment and found it inhibited ( Figure 4C and Figure S3G ). Furthermore, nuclear translocation of β -catenin was completely blocked ( Figure 4D ). Downstream, β -catenin interacts with transcription factors of the TCF/LEF family. The TOPfl ash luciferase reporter activity assay is an established readout of β -catenin/ TCF/LEF interaction. TOPfl ash activity was reduced in Dpr1depleted cardiomyocytes, and Wnt3a stimulation failed to enhance TOPfl ash reporter activation ( Figure 4E ); Conversely, Dpr1 overexpression enhances both β -catenin and TCF/LEF reporter activity under basal conditions and synergized with the effect of Wnt3a ( Figure 5F and 5G , Figure S3H ).
Dpr1-Induced Activation of Canonical Wnt Signaling Is Dvl2 Dependent
Correlation between the protein abundances of Dpr1 and Dvl2 was observed in Dpr1-tg mice, in Dpr1-depleted cardiomyocytes, and furthermore in cardiomyocytes, cultured in hypoxia conditions ( Figure 1B , Figure 5A and 5B). We next determined whether there is a causal association between inhibition of the canonical Wnt pathway and the downregulation of Dvl2 observed in Dpr1 knockdown cells. Dpr1 was coprecipitated with Dvl2 in cultured cardiomyocytes, indicating a physical interaction ( Figure 5C ). Reciprocal downregulation of Dpr1 in Dvl2-depleted cardiomyocytes was not observed ( Figure 5D ), suggesting Dpr1 regulates Wnt upstream of Dvl2. However, Wnt3a-induced activation of canonical Wnt signaling also failed in these cells. Neither β -catenin activation ( Figure 5E and 5F) nor TCF/LEF reporter activity ( Figure 5G ) was increased after Wnt3a stimulation. In addition, Dpr1-induced TOPfl ash reporter activation was completely inhibited in cells lacking Dvl2 ( Figure 5H ), demonstrating that Dvl2 is a required cofactor for transmitting canonical Wnt signals downstream of Dpr1.
Wnt3a-and PE-Induced Hypertrophy Is Inhibited in Dpr1-Depleted Cardiomyocytes
Myocyte surface area increased in response to Wnt3a stimulation ( Figure S4A ) as did protein synthesis ( Figure S4B ), indicating that stimulation of the canonical Wnt pathway alone is suffi cient to induce a hypertrophic response. In a complementary approach, we found that Dpr1 depletion and concomitant inhibition of the canonical Wnt pathway rescued Wnt3a-induced cardiomyocyte hypertrophy. The cardiomyocyte surface area was smaller in Dpr1 knockdown cells ( Figure S4A) , and Wnt3a-induced protein synthesis was completely blocked, indicating that Dpr1 is required for Wnt3a-induced hypertrophy ( Figure S4B ). In addition, Dpr1 depletion moderately inhibited PE-induced cardiac myocyte hypertrophy ( Figure S4C ). Even more apparent was the fact that PE treatment strongly enhanced protein synthesis in control cardiomyocytes, whereas Dpr1-depleted cells completely blocked PE-induced protein synthesis, indicating a crucial role of Dpr1 in PE-mediated cardiomyocyte hypertrophy ( Figure S4D ).
Discussion
Here, we demonstrate that in cardiac myocytes Dpr1 activates rather than inhibiting canonical Wnt signaling, which is suffi cient to induce hypertrophy in cardiac tissue and in isolated cardiomyocytes. In our Dpr1-tg mouse model, cardiac hypertrophy went along with stabilized β -catenin and robust expression of canonical Wnt target genes. These observations are in agreement with earlier reports of a relationship between β -catenin accumulation and cardiomyopathy. 9 -11 Rezvani and Liew 12 observed post-translational regulation of β -catenin by adenomatous polyposis coli in hypertrophic hearts. Mice expressing a nondegradable form of β -catenin developed dilated cardiomyopathy and died after 5 months of age. 13 After transverse aortic constriction, heart weight and cardiomyocyte width were signifi cantly smaller in mice with cardiac-specifi c conditional β -catenin depletion. 9 Contrary to our fi ndings, Baurand et al 14 observed that cardiac-restricted β -catenin depletion in mice was required for adaptive cardiac hypertrophy, whereas heart-specifi c stabilization of β -catenin reduced cardiac growth. However, in their study, depletion or stabilization of β -catenin is not a result of upstream Wnt signaling transduction but is rather an exclusive modifi cation attributable to β -catenin expression. Transduction of the Wnt cascade, from ligand/receptor binding to target gene expression, recruits various cofactors and transcription factors that may play crucial roles in eliciting cardiac hypertrophy.
Dpr1 overexpression increased Dvl2 protein and mRNA abundance. Although the Dvl proteins exist in 3 isoforms (Dvl1 -Dvl3) in mammalian cells, their quantitative distribution is not balanced. Dvl2 constitutes > 95% of the total Dvl1-3 pool in mouse F9 cells and 80% of the pool in mouse P19 and human embryonic kidney 293 cells. However, modifi cation of Dvl2 expression has the least effect on canonical Wnt signaling. 7 Previous studies characterized a functional interaction between Dpr1 and Dvl2 in modulating Wnt activity. This occurs through hydrogen bonds between their PDZ domains. 15 However, their combined role in transmitting Wnt signals is still unexplored. Overexpression of Dpr1 in HeLa cells blocks Dvl2-induced activation of the canonical Wnt cascade. In contrast, Dpr1 In addition, Dpr1-induced TOPfl ash reporter activation was completely inhibited in cells lacking Dvl2 ( Figure 5H ), demonstrating that Dvl2 is a required cofactor for transmitting canonical Wnt signals downstream of Dpr1.
Wnt3a-and PE-Induced Hypertrophy Is Inhibited in Dpr1-Depleted Cardiomyocytes
Myocyte surface area increased in response to Wnt3a stimulation ( Figure S4A ) as did protein synthesis ( Figure S4B ), indicating that stimulation of the canonical Wnt pathway are in agreement with earlier reports of a relationship between β -catenin accumulation and cardiomyopathy. Liew 12 observed post-translational regulation of by adenomatous polyposis coli in hypertrophic hearts. Mice expressing a nondegradable form of β -catenin developed dilated cardiomyopathy and died after 5 months of age. transverse aortic constriction, heart weight and cardiomyocyte width were signifi cantly smaller in mice with cardiac-specifi c conditional β -catenin depletion. 9 Contrary to our fi ndings, Baurand et al cyclinD1, and myoD. All data are presented as mean ± SEM; * P < 0.05 vs WT, n=7 animals each group for protein analysis; n P < 0.05 vs WT, n=7 animals each group for protein analysis; n P each group for RNA analysis.
by guest on July 11, 2017 http://hyper.ahajournals.org/ Downloaded from seems to be an essential Dvl cofactor for induction of the secondary axis in Xenopus embryos, a common feature to verify canonical Wnt signaling activity. 16 In Xenopus , Dpr1 is required for notochord formation by antagonizing Wnt/ βcatenin and JNK signaling. 15 Downregulation of Dpr1 in human hepatocellular carcinoma cells correlates with accumulation of β -catenin, indicating that Dpr1 acts as a canonical/ β -catenin Wnt inhibitor. 17 In Dpr1-tg mice, upregulation of Dvl2 was accompanied by stabilized β -catenin, its translocation into the nucleus, and increased β -catenin target gene expression. On the basis of this, we propose that canonical Wnt signals are transduced by Dvl2. In Dpr1-depleted cardiomyocytes, inhibition of the canonical Wnt pathway was associated with downregulation of Dvl2, suggesting Dpr1 as a crucial cofactor exclusive to Dvl2-mediated Wnt signaling (for suggested pathway, see Figure 6 ). Conversely, knockdown of Dvl2 did not alter Dpr1 abundance, indicating that Dpr1 operates upstream of Dvl2 in the Wnt cascade. This hypothesis is further supported by our observation that Dpr1 overexpression in Dvl2-depleted cardiomyocytes failed to activate TOPfl ash activity. Although Wnt3a-induced Wnt activity was blocked in Dvl2-depleted cells, endogenous Wnt signaling remained active, which is indicated by unaltered activated β -catenin levels ( Figure 5B ). This may be attributable to the redundancy of Dvl isoforms (Dvl1/Dvl3 may compensate for the absence of Dvl2, at least under baseline conditions). Our fi ndings are supported by the results of a recent published study, where Dpr1 was suggested as a positive regulator of canonical Wnt signaling in colon cancer cells. 18 This study highlights that single Wnt components have a tissue-and context-dependent function. Although overexpression of Dpr1 in HeLa cells promotes lysosomal Dvl2 degradation, the situation in cardiac tissue and in isolated cardiomyocytes is contrary. 19 The crucial role of the Wnt pathway in development, cell differentiation, and cell proliferation may provide an explanation because coordination of these sensitive processes requires fl exible properties in a subset of Wnt components. Thus, the complex role of Wnt members, especially in the process of cardiac remodeling, is still a challenging fi eld to investigate in future studies.
Perspectives
This study demonstrates that cardiac-restricted overexpression of Dpr1 activates the canonical Wnt signaling pathway in a Dvl2-dependent manner. Our observations of Dpr1-depleted cardiomyocytes suggest that Dpr1 is a necessary and suffi cient modulator of Wnt3a-mediated activation of the canonical Wnt branch. Moreover, stimulation of this pathway alone is suffi cient to induce hypertrophy in cardiac tissue and in cultured cardiomyocytes. Blocking this pathway may thus serve as a novel therapeutic strategy for governing myocardial remodeling processes and alleviating cardiac hypertrophy. This study highlights that single Wnt components have a tissue-and context-dependent function. Although overexpression of Dpr1 in HeLa cells promotes lysosomal Dvl2 degradation, the situation in cardiac tissue and in isolated cardiomyocytes is contrary. 19 The crucial role of the Wnt pathway in development, cell differentiation, and cell proliferation may provide an explanation because coordination
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